SavedAdd your journal

Journals / Turkish Journal of Internal Medicine / 2026 / Volume: 4 Special Issue

Development of AA Amyloidosis in a Patient with Psoriasis: A Case Report

Mehmet Sezen(ULUDAG UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, NEPHROLOGY (MEDICINE))0000-0001-5796-6445
Müge Şahin(ULUDAG UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF INTERNAL MEDICINE)0000-0002-7348-2771
Abdülmecit Yıldız(ULUDAG UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, NEPHROLOGY (MEDICINE))0000-0001-5941-9103
Ayşegül Oruç(ULUDAG UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, NEPHROLOGY (MEDICINE))0000-0002-0342-9692
Saide Güllülü(ULUDAG UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, NEPHROLOGY (MEDICINE))0000-0001-6048-1879
Mahmut Yavuz(ULUDAG UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, NEPHROLOGY (MEDICINE))0000-0001-6755-6386
Mustafa Güllülü(ULUDAG UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, NEPHROLOGY (MEDICINE))0000-0002-8911-7189
Kamil Dilek(ULUDAG UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, NEPHROLOGY (MEDICINE))0000-0001-6149-1913
Alparslan Ersoy(ULUDAG UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, NEPHROLOGY (MEDICINE))0000-0002-0710-0923
Pages
—
Publication Date
2022-04-01
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Herein, we presented a case of psoriasis who developed AA-type amyloidosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Psoriasis is a chronic, recurrent, inflammatory and common skin disease of unknown aetiology.
📊
Key Findings & Data:Amyloidosis is defined as a heterogeneous group of diseases in which generally soluble plasma proteins accumulate in the extracellular space as insoluble abnormal fibrils.
💡
Conclusion & Impact:Herein, we presented a case of psoriasis who developed AA-type amyloidosis.
🔬Design:Case Report
📍Scope:Comprehensive Sample
⚙️Variables:amyloidosis · Psoriasis · inflammatory skin disease

Abstract

Psoriasis is a chronic, recurrent, inflammatory and common skin disease of unknown aetiology. Amyloidosis is defined as a heterogeneous group of diseases in which generally soluble plasma proteins accumulate in the extracellular space as insoluble abnormal fibrils. Type AA amyloidosis is a late and severe complication of chronic inflammatory disorders and some chronic infections. Although psoriasis is a common inflammatory skin disease, the development of amyloidosis is rare. Herein, we presented a case of psoriasis who developed AA-type amyloidosis.

🔖

Cite This Article

Sezen, M., Şahin, M., Yıldız, A., Oruç, A., Güllülü, S., Yavuz, M., Güllülü, M., Dilek, K., Ersoy, A. (2022). Development of AA Amyloidosis in a Patient with Psoriasis: A Case Report. Turkish Journal of Internal Medicine, Volume: 4 Special Issue. https://doi.org/10.46310/tjim.1072829

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Röcken C, Shakespeare A. Pathology, diagnosis and pathogenesis of AA amyloidosis. Virchows Arch. 2002 Feb;440(2):111-22. doi: 10.1007/s00428-001-0582-9.
  2. Mansur AT, Akbayır N, Gündüz S, Peker Ö. Gastrointestinal amyloidosis in a patient with generalized pustular and arthropathic psoriasis. Turkderm-Turk Arch Dermatol Venereol. 2006;40(B):60-3 (in Turkish).
  3. Kagana A, Husza’r M, Frumkinc A, Rapoporta J. Reversal of nephrotic syndrome due to aa amyloidosis in psoriatic patients onlong-term colchicine treatment: Case report and review of the literature. Nephron 1999;82:348-53. doi: 10.1159/000045450.
  4. Wittenberg GP, Oursler JR, Peters MS. Secondary amyloidosis complicating psoriasis. J Am Acad Dermatol. 1995 Mar;32(3):465- 8. doi: 10.1016/0190-9622(95)90070-5.
  5. Karakoç Y, Dalkılıç E, Güllülü M, Yavuz M, Ersoy A, Yurtkuran M. Renal amyloidosis in rheumatic diseases. Office Journal of the Turkish Nephrology Association. 1999;3:143-6 (in Turkish).
  6. Akar S, Solmaz D. The reflection of disease progression in axial spondylarthritis to the imaging.Ulus Romatol Derg. 2020;12(Suppl 2):54-66. doi: 10.4274/raed.galenos.2020.S108.
  7. Cansu SÜ, Korkmaz C. Psoriatic arthritis treatment: 2015 Update. Osmangazi Journal of Medicine, 2016;38(1):17.25 (in Turkish). doi: 10.20515/otd.91313.
  8. Aytuğar E, Pekiner FM. Behçet hastalığı. Journal of Marmara University Institute of Health Sciences. 2011;1(1):65-73 (in Turkish).
  9. Mérida E, Praga M. NSAIDs and nephrotic syndrome. Clin J Am Soc Nephrol. 2019 Sep 6;14(9):1280-2. doi: 10.2215/ CJN.08090719.
  10. Lachmann HJ, Hawkins PN. Systemic amyloidosis. Curr Opin Pharmacol. 2006 Apr;6(2):214-20. doi: 10.1016/j. coph.2005.10.005.